{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:55:49Z","timestamp":1790700949526,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","exphem.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.exphem.2016.01.005","type":"journal-article","created":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T02:48:14Z","timestamp":1456454894000},"page":"390-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Direct evidence of complement activation in HELLP syndrome: A link to\u00a0atypical hemolytic uremic syndrome"],"prefix":"10.1016","volume":"44","author":[{"given":"Arthur J.","family":"Vaught","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Gavriilaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Hueppchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Blakemore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"York","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Brodsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2016.01.005_bib1","first-page":"1122","article-title":"Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Hypertension in pregnancy: Executive summary","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.exphem.2016.01.005_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/10641950701366825","article-title":"New-onset hypertension in late pregnancy and fetal growth: Different associations between singletons and twins","volume":"26","author":"Chen","year":"2007","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.exphem.2016.01.005_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/14767058.2015.1114081","article-title":"Pre-eclampsia and preterm birth in Reunion Island: A 13 years cohort based study. Comparison with international data","author":"Iacobelli","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.exphem.2016.01.005_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0002-9378(16)32330-4","article-title":"Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy","volume":"142","author":"Weinstein","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.exphem.2016.01.005_bib5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0002-9378(86)90266-8","article-title":"Maternal\u2013perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia","volume":"155","author":"Sibai","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.exphem.2016.01.005_bib6","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0002-9378(99)70022-0","article-title":"The spectrum of severe preeclampsia: Comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification","volume":"180","author":"Martin","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.exphem.2016.01.005_bib7","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0002-9378(96)70162-X","article-title":"Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome","volume":"175","author":"Audibert","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.exphem.2016.01.005_bib8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/01.AOG.0000126245.35811.2a","article-title":"Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"103","author":"Sibai","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.exphem.2016.01.005_bib9","doi-asserted-by":"crossref","first-page":"147.e1","DOI":"10.1016\/j.ajog.2006.09.014","article-title":"Trends in neonatal morbidity and mortality for very low birthweight infants","volume":"196","author":"Fanaroff","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.exphem.2016.01.005_bib10","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/AOG.0000000000000140","article-title":"Risk factors, management, and outcomes of hemolysis, elevated liver enzymes, and low platelets syndrome and elevated liver enzymes, low platelets syndrome","volume":"123","author":"Fitzpatrick","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.exphem.2016.01.005_bib11","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.ajog.2005.08.044","article-title":"Understanding and managing HELLP syndrome: The integral role of aggressive glucocorticoids for mother and child","volume":"195","author":"Martin","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.exphem.2016.01.005_bib12","first-page":"467","article-title":"Pre-eclampsia: Pathophysiology, diagnosis, and management","volume":"7","author":"Uzan","year":"2011","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.exphem.2016.01.005_bib13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2141.2008.07324.x","article-title":"Advances in understanding of pathogenesis of aHUS and HELLP","volume":"143","author":"Fang","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2016.01.005_bib14","first-page":"698","article-title":"Enhanced anaphylatoxin and terminal C5b-9 complement complex formation in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"76","author":"Haeger","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.exphem.2016.01.005_bib15","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/HYPERTENSIONAHA.113.01420","article-title":"Urinary excretion of C5b-9 in severe preeclampsia: Tipping the balance of complement activation in pregnancy","volume":"62","author":"Burwick","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.exphem.2016.01.005_bib16","doi-asserted-by":"crossref","first-page":"e1001013","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: A genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.exphem.2016.01.005_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.blre.2014.01.003","article-title":"Diagnosis and management of complement mediated thrombotic microangiopathies","volume":"28","author":"Cataland","year":"2014","journal-title":"Blood Rev"},{"key":"10.1016\/j.exphem.2016.01.005_bib18","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt1344","article-title":"Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"25","author":"Rother","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.exphem.2016.01.005_bib19","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2016.01.005_bib20","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood-2007-06-094136","article-title":"Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria","volume":"111","author":"Brodsky","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.01.005_bib21","first-page":"1379","article-title":"Eculizumab in atypical hemolytic-uremic syndrome","volume":"369","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2016.01.005_bib22","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2016.01.005_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.placenta.2012.11.014","article-title":"Eculizumab for the treatment of preeclampsia\/HELLP syndrome","volume":"34","author":"Burwick","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.exphem.2016.01.005_bib24","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1182\/blood-2015-02-629683","article-title":"Modified Ham test for atypical hemolytic uremic syndrome","volume":"125","author":"Gavriilaki","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.01.005_bib25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1172\/JCI101081","article-title":"Studies on destruction of red blood cells. II. Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria: Certain immunological aspects of the hemolytic mechanism with special reference to serum complement","volume":"18","author":"Ham","year":"1939","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2016.01.005_bib26","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1182\/blood-2015-06-640995","article-title":"Complement in hemolytic anemia","volume":"126","author":"Brodsky","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.01.005_bib27","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","article-title":"Paroxysmal nocturnal hemoglobinuria","volume":"124","author":"Brodsky","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.01.005_bib28","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1182\/blood-2011-12-398792","article-title":"The complement receptor 2\/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment","volume":"119","author":"Risitano","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.01.005_bib29","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2013-12-547067","article-title":"Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP","volume":"123","author":"Cataland","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.01.005_bib30","doi-asserted-by":"crossref","first-page":"E1445","DOI":"10.1002\/humu.21256","article-title":"Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome","volume":"31","author":"Maga","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.exphem.2016.01.005_bib31","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s00467-010-1555-5","article-title":"Genetics and complement in atypical HUS","volume":"25","author":"Kavanagh","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.exphem.2016.01.005_bib32","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2016.01.005_bib33","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.exphem.2016.01.005_bib34","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJMoa1502950","article-title":"Eculizumab in pregnant patients with paroxysmal nocturnal hemoglobinuria","volume":"373","author":"Kelly","year":"2015","journal-title":"NEJM"},{"key":"10.1016\/j.exphem.2016.01.005_bib35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ccr3.161","article-title":"Increased eculizumab requirements during pregnancy in a patient with paroxysmal nocturnal hemoglobinuria: Case report and review of the literature","volume":"3","author":"Patriquin","year":"2015","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.exphem.2016.01.005_bib36","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.imbio.2014.11.003","article-title":"Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn","volume":"220","author":"Hallstensen","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.exphem.2016.01.005_bib37","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.leukres.2009.10.025","article-title":"Managing a pregnant patient with paroxysmal nocturnal hemoglobinuria in the era of eculizumab","volume":"34","author":"Danilov","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2016.01.005_bib38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/AOG.0b013e31828e2612","article-title":"Eculizumab for atypical hemolytic uremic syndrome in pregnancy","volume":"122","author":"Ardissino","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.exphem.2016.01.005_bib39","first-page":"1421","article-title":"Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome","volume":"93","author":"Canigral","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2016.01.005_bib40","doi-asserted-by":"crossref","first-page":"A119","DOI":"10.1136\/fetalneonatal-2012-301809.388","article-title":"Pregnancy outcome and safety of breast-feeding in two patients with paroxysmal nocturnal haemoglobinuria (PNH) treated with eculizumab","volume":"97","author":"Sarris","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.exphem.2016.01.005_bib41","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2007-04-084533","article-title":"Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome","volume":"111","author":"Fang","year":"2008","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X16000345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X16000345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T17:53:21Z","timestamp":1536947601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X16000345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0301472X16000345"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2016.01.005","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726178402.793517761","asserted-by":"object"}]},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct evidence of complement activation in HELLP syndrome: A link to\u00a0atypical hemolytic uremic syndrome","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2016.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}